| Dr Deepan Shailesh Dalal, MD, MPH | |
|
725 Reservoir Ave Ste 204, Cranston, RI 02910-4451 | |
| (401) 563-9825 | |
| (401) 563-9826 |
| Full Name | Dr Deepan Shailesh Dalal |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 17 Years |
| Location | 725 Reservoir Ave Ste 204, Cranston, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962720441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD14861 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Miriam Hospital | Providence, RI | Hospital |
| Our Lady Of Fatima Hospital | North providence, RI | Hospital |
| Rhode Island Hospital | Providence, RI | Hospital |
| South County Hospital Inc | Wakefield, RI | Hospital |
| Newport Hospital | Newport, RI | Hospital |
| Entity Name | Brown Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689626764 PECOS PAC ID: 0446159776 Enrollment ID: O20040219000354 |
News Archive
Caris Life Sciences and investigators from Inova Fairfax Hospital presented the first clinical outcomes data presentation from the Caris Registry™ at the 50th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill., this weekend.
Results from four innovative studies help answer outstanding questions about stem cell transplant procedures in treating various hematologic malignancies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology reveals that there is no increase in overall cancer risk in people who donate stem cells and that the utilization of a double cord blood stem cell transplant is associated with better overall outcomes when used early in the treatment of acute leukemias.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, has filed an answer and counterclaim to a complaint filed by Tekmira Pharmaceuticals Corporation in the Business Litigation Session (BLS) of the Massachusetts Superior Court.
Atherosclerosis, a disease in which plaque builds up inside arteries, is a prolific and invisible killer, but it may soon lose its ability to hide in the body and wreak havoc. Scientists have now developed a nanoparticle that functionally mimics nature's own high-density lipoprotein (HDL). The nanoparticle can simultaneously light up and treat atherosclerotic plaques that clog arteries. Therapy with this approach could someday help prevent deadly heart attacks and strokes.
› Verified 8 days ago
| Entity Name | Ri Rheumatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194487603 PECOS PAC ID: 0042601965 Enrollment ID: O20220103000115 |
News Archive
Caris Life Sciences and investigators from Inova Fairfax Hospital presented the first clinical outcomes data presentation from the Caris Registry™ at the 50th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill., this weekend.
Results from four innovative studies help answer outstanding questions about stem cell transplant procedures in treating various hematologic malignancies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology reveals that there is no increase in overall cancer risk in people who donate stem cells and that the utilization of a double cord blood stem cell transplant is associated with better overall outcomes when used early in the treatment of acute leukemias.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, has filed an answer and counterclaim to a complaint filed by Tekmira Pharmaceuticals Corporation in the Business Litigation Session (BLS) of the Massachusetts Superior Court.
Atherosclerosis, a disease in which plaque builds up inside arteries, is a prolific and invisible killer, but it may soon lose its ability to hide in the body and wreak havoc. Scientists have now developed a nanoparticle that functionally mimics nature's own high-density lipoprotein (HDL). The nanoparticle can simultaneously light up and treat atherosclerotic plaques that clog arteries. Therapy with this approach could someday help prevent deadly heart attacks and strokes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Deepan Shailesh Dalal, MD, MPH 725 Reservoir Ave, Suite 204, Cranston, RI 02910-4451 Ph: (401) 563-9825 | Dr Deepan Shailesh Dalal, MD, MPH 725 Reservoir Ave Ste 204, Cranston, RI 02910-4451 Ph: (401) 563-9825 |
News Archive
Caris Life Sciences and investigators from Inova Fairfax Hospital presented the first clinical outcomes data presentation from the Caris Registry™ at the 50th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill., this weekend.
Results from four innovative studies help answer outstanding questions about stem cell transplant procedures in treating various hematologic malignancies. Research that will be presented today at the 52nd Annual Meeting of the American Society of Hematology reveals that there is no increase in overall cancer risk in people who donate stem cells and that the utilization of a double cord blood stem cell transplant is associated with better overall outcomes when used early in the treatment of acute leukemias.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, has filed an answer and counterclaim to a complaint filed by Tekmira Pharmaceuticals Corporation in the Business Litigation Session (BLS) of the Massachusetts Superior Court.
Atherosclerosis, a disease in which plaque builds up inside arteries, is a prolific and invisible killer, but it may soon lose its ability to hide in the body and wreak havoc. Scientists have now developed a nanoparticle that functionally mimics nature's own high-density lipoprotein (HDL). The nanoparticle can simultaneously light up and treat atherosclerotic plaques that clog arteries. Therapy with this approach could someday help prevent deadly heart attacks and strokes.
› Verified 8 days ago
Susan H Hart, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1052 Park Ave, Cranston, RI 02910 Phone: 401-275-5039 | |
Thomas Henry Mcgreen, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1150 Reservoir Ave, Suite 201, Cranston, RI 02920 Phone: 401-943-1300 Fax: 401-946-8480 | |
Dr. Gregory G Allen, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1681 Cranston St, Suite D, Cranston, RI 02920 Phone: 401-946-8446 Fax: 401-946-8340 | |
Dr. Robert L Graves, D.O. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1150 Reservoir Ave, Suite 304, Cranston, RI 02920 Phone: 401-942-3330 Fax: 401-942-3833 | |
Dr. Robert John Bierwirth, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1150 Reservoir Ave, Suite 201, Cranston, RI 02920 Phone: 401-943-1300 | |
Dr. Steven Michael Sepe, M.D., PH.D Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 25 Belle Isle Way, Cranston, RI 02921 Phone: 401-942-7843 Fax: 401-942-7843 | |
Ms. Jun O Parks, M. D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 333 Budlong Rd, Cranston, RI 02920 Phone: 401-943-4530 |